Pancreatic Insufficiency
Links shared publicly online about this topic
Coeliac disease and pancreatic exocrine insufficiency
pharmaceutical-int.com — “The following article published by Pharmaceutical International concerns Coeliac disease and pancreatic exocrine insufficiency Introduced by Schebo Biotech.” View full resource at pharmaceutical-int.com
Most Recently Shared on May 8, 2009 at 12:22 am By:
Steve Nenninger CAM and Naturopathic Doctor
A large number of people that are gluten sensitive also have pancreatic damage. Hence ongoing digestive problems.http://bit.ly/8tCXF
eMJA: Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations
mja.com.au — “(Medical Journal of Australia) Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations” View full resource at mja.com.au
Most Recently Shared on October 18, 2010 at 12:00 am By:
Gastroenterology Upd Gastroenterology and Medical Publisher
Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations http://bit.ly/9AzsVW
FDA Approves Pancreatic Enzyme Product, Pancreaze
drugs.com — “Pancreaze (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Pancreaze side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 13, 2010 at 11:44 pm By:
FDA Approves Pancreatic Enzyme Product, Pancreaze - http://bit.ly/c6pGCd
Medical News: FDA Panel Rejects Cystic Fibrosis Drug - in Gastroenterology, Pancreatic Diseases from MedPage Today
medpagetoday.com — “SILVER SPRING, Md. -- An FDA advisory committee has voted against approval of liprotamase (Sollpura), a pancreatic enzyme product for cystic fibrosis and other diseases that cause pancreatic insuffici” View full resource at medpagetoday.com
Most Recently Shared on January 12, 2011 at 11:37 pm By:
FDA Panel Rejects Cystic Fibrosis Drug http://bit.ly/hSR3Ue
Endothelin-1 inhibitors in chronic pancreatitis
physorg.com — “Fibrosis is a key feature of chronic pancreatitis and pancreatic cancer. The extensive deposition of extracellular matrix proteins fosters the development of an exocrine and endocrine organ insufficiency, and accelerates progression of the tumour. Pancreatic stellate cells (PSC) are the principal effector ...” View full resource at physorg.com
Most Recently Shared on September 17, 2009 at 1:15 pm By:
Endothelin-1 inhibitors in chronic pancreatitis http://bit.ly/1IvB1A
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
drugs.com — “Creon (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Creon side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on June 15, 2011 at 12:08 am By:
Drugs and Devices OW OW Health
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pa... http://bit.ly/kZWxyW #drug
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
drugs.com — “Creon (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Creon side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on June 14, 2011 at 11:36 pm By:
FDA Approves Creon (pancrelipase) Infant-Specific Dosage Strength - http://bit.ly/jAdfb4
Pancreaze approved for exocrine pancreatic insufficiency - MPR
empr.com — “The FDA has approved Pancreaze (pancrelipase delayed-release capsules, from McNeil Pediatrics) for the treatment of exocrine pancreatic insufficiency (EPI) due to cystic fibrosis or other conditions.” View full resource at empr.com
Most Recently Shared on April 13, 2010 at 4:27 pm By:
MPR News: Pancreaze approved for exocrine pancreatic insufficiency: The FDA has approved Pancreaze (pancrelipase d... http://bit.ly/bfVFzA
Lilly Receives Complete Response Letter From FDA for Liprotamase for the Treatment of Exocrine Pancreatic Insufficiency
drugs.com — “Trizytek (liprotamase) is a new drug in development for the treatment of pancreatic insufficiency. Trizytek information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on May 5, 2011 at 12:15 am By:
Drugs and Devices OW OW Health
Lilly Receives Complete Response Letter From FDA for Liprotamase for the Treatment of Exocrine Pancreatic ... http://bit.ly/jOU4X2 #drug
Creon delayed-release capsules available for exocrine pancreatic insufficiency - MPR
empr.com — “Solvay Pharmaceuticals has made available Creon (pancrelipase) delayed-release capsules, a zero-overfill pancreatic enzyme product that targets 100% of the lipase amount indicated on the product labeling.” View full resource at empr.com
Most Recently Shared on July 7, 2009 at 9:48 pm By:
MPR News: Creon delayed-release capsules available for exocrine pancreatic insufficiency: Solvay Pharma.. http://tinyurl.com/mzjwfn
FDA Panel Rejects Cystic Fibrosis Drug - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory committee has voted against approval of liprotamase (Sollpura), a pancreatic enzyme product for cystic fibrosis and other diseases that cause pancreatic insufficiency, saying there is not enough evidence that the drug works better than agents already on the market.” View full resource at qualitypointtech.net
Most Recently Shared on January 13, 2011 at 12:01 am By:
FDA Panel Rejects Cystic Fibrosis Drug: (MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory committee has vot... http://bit.ly/hMGMAE
FDA clears Eurand's pancreatic enzyme drug Zenpep - Related Stories - AAP SmartBrief
smartbrief.com — “Eurand in Amsterdam gained FDA approval for its lead product, pancreatic enzyme drug Zenpep, for children age 1 and older as well as adults. The treatment, which is indicated for exocrine pancreatic insufficiency, will be available in four dosages in the U.S. next quarter. <a href='/servlet/aaRedire” View full resource at smartbrief.com
Most Recently Shared on September 1, 2009 at 3:02 am By:
Clara Song Doctor, Pediatrician, and Physician
FDA clears Eurand's pancreatic enzyme drug Zenpep http://sbne.ws/r/2FrT
Eurand Granted FDA Approval for Zenpep
drugs.com — “Zenpep (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Zenpep side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 29, 2009 at 7:33 pm By:
Eurand Granted FDA Approval for Zenpep - http://bit.ly/3I6xA6
Pearson Syndrome: eMedicine Pediatrics: General Medicine
emedicine.medscape.com — “Overview: in 1979, pearson et al described a previously unrecognized, often fatal disorder of infants with transfusion-dependent sideroblastic anemia, vacuolization of hematopoietic precursors, and exocrine pancreatic insufficiency.1 the large deletions of the mitochondrial genome that cause ...” View full resource at emedicine.medscape.com
Most Recently Shared on January 28, 2010 at 10:32 pm By:
Medscape Pediatrics Pediatrics and Health Site
The eMedicine article, Pearson Syndrome, has been updated! Head to http://bit.ly/9T8rAw.
Medical News: FDA Formally Approves Creon Pancrelipase - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- The FDA has approved the Creon brand of delayed-release pancrelipase for treatment of exocrine pancreatic insufficiency.” View full resource at medpagetoday.com
Most Recently Shared on May 1, 2009 at 6:56 pm By:
FDA Formally Approves Pancrelipase http://medpagetoday.com/14021
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Steve Nenninger
Dr. Steve Nenninger NMD ~ Glutenologist ~ Will only post gluten info with tweets. one per day max.
-
Gastroenterology Upd
Gastroenterology Update is a fortnightly PDF newsletter with the latest Australian and international news.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
